Hereditary prion protein amyloidoses

Bernardino Ghetti, Pedro Piccardo, Orso Bugiani, Gianluigi Forloni, Michela Morbin, Mario Salmona, Fabrizio Tagliavini

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

The term prion protein (PrP) amyloidoses is used to describe a group of diseases in which large amounts of PrP degradation products accumulate as fibrillary deposits leading to amyloid formation1,2. Accumulation of abnormal PrP isoforms occurs without significant amyloid deposition in the brain parenchyma during the course of most subacute spongiform encephalopathies, which include sporadic, familial, and iatrogenic Creutzfeldt-Jakob disease (CJD) as well as sporadic and familial fatal insomnia (FFI)3-6. Typically, PrP-amyloid is seen in Gerstmann-Sträussler-Scheinker disease (GSS), PrP cerebral amyloid angiopathy (PrP-CAA), variant CJD (vCJD), and kuru 1-3.

Original languageEnglish
Title of host publicationNeurodegeneration and Prion Disease
PublisherSpringer US
Pages83-109
Number of pages27
ISBN (Print)0387239227, 9780387239224
DOIs
StatePublished - 2005

Fingerprint

Amyloidosis
Creutzfeldt-Jakob Syndrome
Amyloid
Fatal Familial Insomnia
Kuru
Cerebral Amyloid Angiopathy
Prion Diseases
Proteolysis
Protein Isoforms
Prion Proteins
Brain

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Ghetti, B., Piccardo, P., Bugiani, O., Forloni, G., Morbin, M., Salmona, M., & Tagliavini, F. (2005). Hereditary prion protein amyloidoses. In Neurodegeneration and Prion Disease (pp. 83-109). Springer US. https://doi.org/10.1007/0-387-23923-5_4

Hereditary prion protein amyloidoses. / Ghetti, Bernardino; Piccardo, Pedro; Bugiani, Orso; Forloni, Gianluigi; Morbin, Michela; Salmona, Mario; Tagliavini, Fabrizio.

Neurodegeneration and Prion Disease. Springer US, 2005. p. 83-109.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ghetti, B, Piccardo, P, Bugiani, O, Forloni, G, Morbin, M, Salmona, M & Tagliavini, F 2005, Hereditary prion protein amyloidoses. in Neurodegeneration and Prion Disease. Springer US, pp. 83-109. https://doi.org/10.1007/0-387-23923-5_4
Ghetti B, Piccardo P, Bugiani O, Forloni G, Morbin M, Salmona M et al. Hereditary prion protein amyloidoses. In Neurodegeneration and Prion Disease. Springer US. 2005. p. 83-109 https://doi.org/10.1007/0-387-23923-5_4
Ghetti, Bernardino ; Piccardo, Pedro ; Bugiani, Orso ; Forloni, Gianluigi ; Morbin, Michela ; Salmona, Mario ; Tagliavini, Fabrizio. / Hereditary prion protein amyloidoses. Neurodegeneration and Prion Disease. Springer US, 2005. pp. 83-109
@inbook{d0e707b7ee91404b971c9d1a45d776de,
title = "Hereditary prion protein amyloidoses",
abstract = "The term prion protein (PrP) amyloidoses is used to describe a group of diseases in which large amounts of PrP degradation products accumulate as fibrillary deposits leading to amyloid formation1,2. Accumulation of abnormal PrP isoforms occurs without significant amyloid deposition in the brain parenchyma during the course of most subacute spongiform encephalopathies, which include sporadic, familial, and iatrogenic Creutzfeldt-Jakob disease (CJD) as well as sporadic and familial fatal insomnia (FFI)3-6. Typically, PrP-amyloid is seen in Gerstmann-Str{\"a}ussler-Scheinker disease (GSS), PrP cerebral amyloid angiopathy (PrP-CAA), variant CJD (vCJD), and kuru 1-3.",
author = "Bernardino Ghetti and Pedro Piccardo and Orso Bugiani and Gianluigi Forloni and Michela Morbin and Mario Salmona and Fabrizio Tagliavini",
year = "2005",
doi = "10.1007/0-387-23923-5_4",
language = "English",
isbn = "0387239227",
pages = "83--109",
booktitle = "Neurodegeneration and Prion Disease",
publisher = "Springer US",

}

TY - CHAP

T1 - Hereditary prion protein amyloidoses

AU - Ghetti, Bernardino

AU - Piccardo, Pedro

AU - Bugiani, Orso

AU - Forloni, Gianluigi

AU - Morbin, Michela

AU - Salmona, Mario

AU - Tagliavini, Fabrizio

PY - 2005

Y1 - 2005

N2 - The term prion protein (PrP) amyloidoses is used to describe a group of diseases in which large amounts of PrP degradation products accumulate as fibrillary deposits leading to amyloid formation1,2. Accumulation of abnormal PrP isoforms occurs without significant amyloid deposition in the brain parenchyma during the course of most subacute spongiform encephalopathies, which include sporadic, familial, and iatrogenic Creutzfeldt-Jakob disease (CJD) as well as sporadic and familial fatal insomnia (FFI)3-6. Typically, PrP-amyloid is seen in Gerstmann-Sträussler-Scheinker disease (GSS), PrP cerebral amyloid angiopathy (PrP-CAA), variant CJD (vCJD), and kuru 1-3.

AB - The term prion protein (PrP) amyloidoses is used to describe a group of diseases in which large amounts of PrP degradation products accumulate as fibrillary deposits leading to amyloid formation1,2. Accumulation of abnormal PrP isoforms occurs without significant amyloid deposition in the brain parenchyma during the course of most subacute spongiform encephalopathies, which include sporadic, familial, and iatrogenic Creutzfeldt-Jakob disease (CJD) as well as sporadic and familial fatal insomnia (FFI)3-6. Typically, PrP-amyloid is seen in Gerstmann-Sträussler-Scheinker disease (GSS), PrP cerebral amyloid angiopathy (PrP-CAA), variant CJD (vCJD), and kuru 1-3.

UR - http://www.scopus.com/inward/record.url?scp=84855498241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855498241&partnerID=8YFLogxK

U2 - 10.1007/0-387-23923-5_4

DO - 10.1007/0-387-23923-5_4

M3 - Chapter

SN - 0387239227

SN - 9780387239224

SP - 83

EP - 109

BT - Neurodegeneration and Prion Disease

PB - Springer US

ER -